An article published in Cardiovascular Business covers Parasol Med Tech’s $2.75 million pre-seed funding round, including participation from Cardiovascular Innovation Ventures, Harper Court Ventures, and UChicago Medicine Ventures.
The coverage highlights Parasol’s investigational catheter-and-gel approach to left atrial appendage closure and the company’s efforts to advance its technology through further development and testing.
Source: Cardiovascular Business
Author: Dave Fornell
Published: October 27, 2026